The Shackles of Practice: History of psychology, research assessment and the curriculum

The history of psychology is being increasingly marginalized in British universities. In this article we argue that this marginalization has been brought about by a combination of material circumstances resulting from the marketization of the UK Higher Education sector. One consequence of this, the statutory audit known as the Research Excellence Framework, has made it increasingly difficult to undertake historical work as it has traditionally been done in UK Psychology Departments. At best such a situation challenges the ambition for historical work to have an impact on psychology. At worst it potentially renders the history of psychology irrelevant. Yet the theoretical justification for history of psychology has never been stronger. Psychology’s subject matter is neither exclusively natural nor entirely socially constructed, but lies on that “somewhat suspect borderland between physiology and philosophy” as Wilhelm Wundt put it. The discipline’s ontological claims are therefore always made from within epistemological frameworks which are themselves products of particular historical contexts. Such arguments have persuaded us that history of psychology has a fundamental role to play within the wider discipline. Yet as historians we cannot ignore the constraining social and material circumstances in which our field operates. We conclude that although the constraints of practice suggest that its prospects for influencing its parent discipline are seriously challenged, there are nevertheless opportunities for the history of psychology areas such as the undergraduate curriculum

The OPERA trial : protocol for a randomised trial of an exercise intervention for older people in residential and nursing accommodation

Background Depression is common in residents of Residential and Nursing homes (RNHs). It is usually undetected and often undertreated. Depression is associated with poor outcomes including increased morbidity and mortality. Exercise has potential to improve depression, and has been shown in existing trials to improve outcomes among younger and older people. Existing evidence comes from trials that are short, underpowered and not from RNH settings. The aim of the OPERA trial is to establish whether exercise is effective in reducing the prevalence of depression among older RNH residents. Method OPERA is a cluster randomised controlled trial. RNHs are randomised to one of two groups with interventions lasting 12 months Intervention group: a depression awareness and physical activity training session for care home staff, plus a whole home physical activation programme including twice weekly physiotherapist-led exercise groups. The intervention lasts for one year from randomisation, or Control group: a depression awareness training session for care home staff. Participants are people aged 65 or over who are free of severe cognitive impairment and willing to participate in the study. Our primary outcome is the prevalence of depressive symptoms, a GDS-15 score of five or more, in all participants at the end of the one year intervention period. Our secondary depression outcomes include remission of depressive symptoms and change in GDS-15 scores in those with depressive symptoms prior to randomisation. Other secondary outcomes include, fear of falling, mobility, fractures, pain, cognition, costs and health related quality of life. We aimed to randomise 77 RNHs. Discussion Home recruitment was completed in May 2010; 78 homes have been randomised. Follow up will finish in May 2011 and results will be available late 2011

Breaking habits using implementation intentions

In this chapter we discuss how, and under which conditions, implementation intentions can be used to overcome unwanted habits, with a focus on unhealthy eating habits. We will highlight the mechanisms by which implementation intentions are (in)effective in changing habits generally, as well as decreasing unwanted habits specifically. We will demonstrate that implementation intentions can be helpful to change habits, but also that there are several boundary conditions to their effectiveness, especially when they are applied to complex habits in the real world. We attempt to provide some useful guidelines for formulating effective plans and we will discuss potential solutions to deal with the limitations when applying implementation intentions in practical contexts. We elaborate on the usefulness of combining the formation of implementation intentions with other strategies, for example aimed at fostering insights into the cues triggering the habitual behaviour and establishing strong cue-response links. In this way, we hope to provide the reader with crucial information to maximally benefit from implementation intentions to break unwanted habits

Molecular Basis of Cannabis-Induced Schizophrenia-Relevant Behaviours: Insights from Animal Models

Introduction: Cannabis use is a well-established component risk factor for schizophrenia; however, the mechanisms by which cannabis use increases schizophrenia risk are unclear. Animal models can elucidate mechanisms by which chronic cannabinoid treatment can induce schizophrenia-relevant neural changes, in a standardised manner often not possible using patient-based data. Methods: We review recent literature (within the past 10 years) using animal models of chronic and subchronic treatment with cannabinoids which target the cannabinoid 1 receptor [i.e. ∆9-tetrahydrocannabinol, CP55,940 and WIN55,212-2]. Schizophrenia-relevant behavioural consequences of chronic cannabinoid treatment are first briefly summarised, followed by a detailed account of changes to several receptor systems [e.g. cannabinoid, dopaminergic, glutamatergic, γ-aminobutyric acid (GABAe)rgic, serotonergic, noradrenergic], dendritic spine morphology and inflammatory markers following chronic cannabinoids. We distinguish between adolescent and adult cannabinoid treatments, to determine if adolescence is a period of susceptibility to schizophrenia-relevant molecular changes. Results: Chronic cannabinoid treatment induces behaviours relevant to positive, negative and cognitive symptoms of schizophrenia. Chronic cannabinoids also cause region- and subtype-specific changes to receptor systems (e.g. cannabinoid, dopaminergic, glutamatergic, GABAergic), as well as changes in dendritic spine morphology and upregulation of inflammatory markers. These changes often align with molecular changes observed in post-mortem tissue from schizophrenia patients and correspond with schizophrenia-relevant behavioural change in rodents. There is some indication that adolescence is a period of susceptibility to cannabinoid-induced schizophrenia-relevant neural change, but more research in this field is required to confirm this hypothesis. Conclusions: Animal models indicate several molecular mechanisms by which chronic cannabinoids contribute to schizophrenia-relevant neural and behavioural change. It is likely that a number of these mechanisms are simultaneously impacted by chronic cannabinoids, thereby increasing schizophrenia risk in individuals who use cannabis. Understanding how cannabinoids can affect several molecular targets provides critical insight into the complex relationship between cannabis use and schizophrenia risk